520 related articles for article (PubMed ID: 24502325)
41. Menopause.
Nelson HD
Lancet; 2008 Mar; 371(9614):760-70. PubMed ID: 18313505
[TBL] [Abstract][Full Text] [Related]
42. Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study.
Haimov-Kochman R; Barak-Glantz E; Arbel R; Leefsma M; Brzezinski A; Milwidsky A; Hochner-Celnikier D
Menopause; 2006; 13(3):370-6. PubMed ID: 16735933
[TBL] [Abstract][Full Text] [Related]
43. Hot flashes: aetiology and management.
Barton D; Loprinzi C; Wahner-Roedler D
Drugs Aging; 2001; 18(8):597-606. PubMed ID: 11587246
[TBL] [Abstract][Full Text] [Related]
44. Hormone therapy for the management of menopausal symptoms: pharmacotherapy update.
Woodis CB
J Pharm Pract; 2010 Dec; 23(6):540-7. PubMed ID: 21507860
[TBL] [Abstract][Full Text] [Related]
45. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
[TBL] [Abstract][Full Text] [Related]
46. [The administration of hormonal replacement therapy].
Suhonen S
Duodecim; 1996; 112(12):1073-80. PubMed ID: 10593008
[No Abstract] [Full Text] [Related]
47. Non-hormonal treatments for menopausal symptoms.
Hickey M; Saunders CM; Stuckey BG
Maturitas; 2007 May; 57(1):85-9. PubMed ID: 17367965
[TBL] [Abstract][Full Text] [Related]
48. Non-hormonal treatments for menopausal symptoms.
Hickey M; Szabo RA; Hunter MS
BMJ; 2017 Nov; 359():j5101. PubMed ID: 29170264
[No Abstract] [Full Text] [Related]
49. "Natural" hormone replacement therapy and dietary supplements used in the treatment of menopausal symptoms.
Taffe AM; Cauffield J
Lippincotts Prim Care Pract; 1998; 2(3):292-302. PubMed ID: 9644444
[No Abstract] [Full Text] [Related]
50. Alternatives to estrogen to manage hot flushes.
Albertazzi P
Gynecol Endocrinol; 2005 Jan; 20(1):13-21. PubMed ID: 15969241
[TBL] [Abstract][Full Text] [Related]
51. Relief of hot flushes with new plant-derived 10-component synthetic conjugated estrogens.
Utian WH; Lederman SA; Williams BM; Vega RY; Koltun WD; Leonard TW
Obstet Gynecol; 2004 Feb; 103(2):245-53. PubMed ID: 14754691
[TBL] [Abstract][Full Text] [Related]
52. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
Stefanick ML
Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of and satisfaction with complementary therapies and hormone replacement therapy in a specialist menopause clinic.
Vashisht A; Domoney CL; Cronje W; Studd JW
Climacteric; 2001 Sep; 4(3):250-6. PubMed ID: 11588949
[TBL] [Abstract][Full Text] [Related]
54. Complementary and alternative medicine use for vasomotor symptoms among women who have discontinued hormone therapy.
Kupferer EM; Dormire SL; Becker H
J Obstet Gynecol Neonatal Nurs; 2009; 38(1):50-9. PubMed ID: 19208048
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of progestin-only treatment for the management of menopausal symptoms: a systematic review.
Dolitsky SN; Cordeiro Mitchell CN; Stadler SS; Segars JH
Menopause; 2020 Nov; 28(2):217-224. PubMed ID: 33109992
[TBL] [Abstract][Full Text] [Related]
56. Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology.
Cortés-Bonilla M; Bernardo-Escudero R; Alonso-Campero R; Francisco-Doce MT; Hernández-Valencia M; Celis-González C; Márquez-Oñate R; Chedraui P; Uribe JA
Gynecol Endocrinol; 2015 Jul; 31(7):552-9. PubMed ID: 26062108
[TBL] [Abstract][Full Text] [Related]
57. Systematic review of progesterone use by midlife and menopausal women.
Spark MJ; Willis J
Maturitas; 2012 Jul; 72(3):192-202. PubMed ID: 22541358
[TBL] [Abstract][Full Text] [Related]
58. Management of Menopause Symptoms and Quality of Life during the Menopause Transition.
Ye L; Knox B; Hickey M
Endocrinol Metab Clin North Am; 2022 Dec; 51(4):817-836. PubMed ID: 36244695
[TBL] [Abstract][Full Text] [Related]
59. A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms.
Lindh-Astrand L; Bixo M; Hirschberg AL; Sundström-Poromaa I; Hammar M
Menopause; 2010; 17(1):72-9. PubMed ID: 19675505
[TBL] [Abstract][Full Text] [Related]
60. An introduction to the Endocrine Society Clinical Practice Guideline on treatment of symptoms of the menopause.
Stuenkel CA; Santen RJ
Post Reprod Health; 2016 Mar; 22(1):6-8. PubMed ID: 26936942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
